Prediagnostic use of low-dose aspirin and risk of incident metastasis and all-cause mortality among patients with colorectal cancer.

Giovanni GiorliJulie RouetteHui YinFrancesco LapiMonica SimonettiClaudio CricelliMichael PollakLaurent Azoulay

Published in: British journal of clinical pharmacology (2020)

In this real-world, population-based study, the prediagnostic use of low-dose aspirin was not associated with a decreased risk of incident metastasis or all-cause mortality in CRC patients.

Keyphrases

low dose
high dose
end stage renal disease
cardiovascular disease
newly diagnosed
ejection fraction
chronic kidney disease
antiplatelet therapy
coronary artery disease
patient reported outcomes
atrial fibrillation
acute coronary syndrome